Migdal Insurance & Financial Holdings Ltd. Codexis, Inc. Transaction History

Migdal Insurance & Financial Holdings Ltd.

$6.97 Billion
Q4 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$17.48 - $25.46 $695,651 - $1.01 Million	-39,797 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$18.08 - $28.8 $446,521 - $711,273	24,697 Added 163.56%	39,797 $911,000
Q4 2020 Feb 08, 2021	BUY	$11.7 - $23.41 $176,670 - $353,491	15,100 New	15,100 $330,000

Others Institutions Holding CDXS

# of Institutions

144

Shares Held

60.6M

Call Options Held

68.5K

Put Options Held

20.1K

Opaleye Management Inc. Boston, MA

8.84M
Shares

$23.2 Million
8.29% of portfolio
Casdin Capital, LLC New York, NY

8.1M
Shares

$21.3 Million
3.32% of portfolio
Black Rock Inc. New York, NY

6.79M
Shares

$17.9 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.46M
Shares

$11.7 Million
0.0% of portfolio
Telemark Asset Management, LLC Boston, MA

3M
Shares

$7.89 Million
1.53% of portfolio

View Full List

About CODEXIS, INC.

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $172M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

More about CDXS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Migdal Insurance & Financial Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Migdal Insurance & Financial Holdings Ltd. with notifications on news.

Account